Global Life Science Ventures

Dr Bert van Toor has been appointed as investment manager for Global Life Science Ventures (GLSV). This appointment continues the planned expansion of the company's investment team in Europe to accommodate GLSV's increased geographic presence in Germany, Switzerland as well as the UK. As a member of the GLSV investment team, Dr van Toor will operate from the company's Zug office in Switzerland. He will be actively involved in evaluating potential investments, developing GLSV's portfolio of companies in the life sciences, and providing further counselling for the management of the fund. Van Toor has over 10 years of experience in senior level positions in the drug discovery and development industry. He qualified as a medical doctor at the University of Amsterdam in 1988 and obtained accreditation as a clinical pharmacologist in Mainz, Germany. He has worked for Boehringer Ingelheim and Bayer AG in several positions including global project management, clinical development and as interim medical director of the Benelux region.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH